Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke A Selth

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Molecular Biology of the Cell|November 29, 2023
Quaking isoforms cooperate to promote the mesenchymal phenotypeDaniel P Neumann, Caroline A Phillips, Rachael Lumb, et al.
The Prostate|July 12, 2012
Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancersKaren Chiam, Natalie K Ryan, Carmela Ricciardelli, et al.
Endocrine-Related Cancer|June 22, 2012
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activityNicole L Moore, Grant Buchanan, Jonathan M Harris, et al.
BMC Cancer|February 25, 2016
IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptorSarah L Carter, Sarah Louise Carter, Margaret M Centenera, et al.
BMC Cancer|October 27, 2015
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeEleanor F Need, Luke A Selth, Andrew P Trotta, et al.
Endocrine-Related Cancer|May 27, 2014
Human seminal fluid as a source of prostate cancer-specific microRNA biomarkersLuke A Selth, Matthew J Roberts, Clement W K Chow, et al.
International Journal of Cancer|January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human diseaseVanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2026
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancerAva Safaroghli-Azar, Travis Croft, Laychiluh B Mekonnen, et al.
Cells|May 13, 2023
Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington's DiseaseLaura Gantley, Brett W Stringer, Vanessa M Conn, et al.
Cancer Research|August 7, 2016
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17Dong G Hu, Luke A Selth, Gerard A Tarulli, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Molecular Biology of the Cell|November 29, 2023
Quaking isoforms cooperate to promote the mesenchymal phenotypeDaniel P Neumann, Caroline A Phillips, Rachael Lumb, et al.
The Prostate|July 12, 2012
Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancersKaren Chiam, Natalie K Ryan, Carmela Ricciardelli, et al.
Endocrine-Related Cancer|June 22, 2012
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activityNicole L Moore, Grant Buchanan, Jonathan M Harris, et al.
BMC Cancer|February 25, 2016
IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptorSarah L Carter, Sarah Louise Carter, Margaret M Centenera, et al.
BMC Cancer|October 27, 2015
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeEleanor F Need, Luke A Selth, Andrew P Trotta, et al.
Endocrine-Related Cancer|May 27, 2014
Human seminal fluid as a source of prostate cancer-specific microRNA biomarkersLuke A Selth, Matthew J Roberts, Clement W K Chow, et al.
International Journal of Cancer|January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human diseaseVanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2026
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancerAva Safaroghli-Azar, Travis Croft, Laychiluh B Mekonnen, et al.
Cells|May 13, 2023
Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington's DiseaseLaura Gantley, Brett W Stringer, Vanessa M Conn, et al.
Cancer Research|August 7, 2016
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17Dong G Hu, Luke A Selth, Gerard A Tarulli, et al.
Pageof 10